HLA-A*0201 & B2M & EBV EBNA3C (LLDFVRFMGV)

HLA-A*0201 & B2M & EBV EBNA3C (LLDFVRFMGV) Product List

  • Product Category

    Protein (2)

  • Product Status

    Launched (2)

  • Species

    Human (2)

  • Tag

    His Tag & Avi Tag (1)His Tag (1)

  • Conjugate

    Biotin-labeled (1)PE Labeled (1)

HLA-A*0201 & B2M & EBV EBNA3C (LLDFVRFMGV) Background

The peptide LLDFVRFMGV, derived from the Epstein-Barr virus nuclear antigen EBNA3C, is presented by the HLA-A*02:01/β2m complex. This peptide-MHC complex serves as a major target for cytotoxic T lymphocytes (CTLs) in the immune control of EBV infection. Its robust immunogenicity makes it a key antigen of interest for studying EBV-specific T-cell responses and for developing immunotherapies against EBV-associated diseases.
  • Product List